Mannkind (MNKD) Directors and Executive Officers

Officers & Directors

Anthony C. Hooper
Director -

Michael E. Castagna
Chief Executive Officer - Dated
Chief Executive Officer and Director - (Principal Executive Officer)

Ronald J. Consiglio
Director -

Christine Mundkur
Director -

Steven B. Binder
Chief Financial Officer - (Principal Financial and Accounting Officer)

Sabrina Kay
Director -

Michael Friedman
Michael Friedman, M.D.
Director -

Jennifer Grancio
Director -

James S. Shannon
James S. Shannon, M.D., MRCP - (UK)
Chairman of the Board of Directors

Kent Kresa
Director - ,

Mannkind Corporation currently has 592 employees.

News about Mannkind Corporation Key Personnel

MannKind Corporation Appoints New President, Reports Record Revenue Growth and Promising Results in Pediatric diabetes Innovations,

MannKind Corporation Expands Leadership and Records Impressive Revenue Growth Danbury, Conn. and Westlake Village, Calif. – On January 6, 2025, MannKind Corporation (Nasdaq: MNKD), a pioneer in the development of innovative inhaled therapeutic products for patients with endocrine disorders and orphan lung diseases, announced a significant addition to its executive team. Dominic Marasco, RPh, has been appointed as the new President of the Endocrine Business Unit. This strategic move is part of MannKind s efforts to strengthen its operations and position itself in the competitive healthcare sector.In conjunction with this leadership expansion, MannKind has also reported remarkable financial growth. The comp...